Osbon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Osbon Capital Management's BMY Position: Q2 2026 in Review
Osbon Capital Management increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $10.3K and bringing the position to 1,194 shares worth $68.8K. The position accounts for 0.05% of the portfolio, ranked #117.
Osbon Capital Management first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Osbon Capital Management held 1,194 shares of Bristol-Myers Squibb worth $68.8K as of Q2 2026.
- Osbon Capital Management bought 180 Bristol-Myers Squibb shares in Q2 2026, an estimated $10.3K.
- Bristol-Myers Squibb made up 0.05% of Osbon Capital Management's portfolio in Q2 2026, its #117 holding.
- Osbon Capital Management first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Osbon Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.